LUMO - Lumos Pharma - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Lumos Pharma's activity chart (see below) currently has 12 price targets and 17 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 50.92% with an average time for these price targets to be met of 243.6 days.

Most recent stock forecast was given by from HC WAINWRIGHT on 08-Nov-2024.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 08-Nov-2024

$4.25

$-0.09 (-2.07%)

$4.25

Buy Since 13-Apr-2021

$4.25

$-0.09 (-2.07%)

$34

Buy Since 16-Apr-2020

$7

$2.66 (61.29%)

Show more analysts

Please expand the browser size to see the chart

What is LUMO (Lumos Pharma) average time for price targets to be met?

On average it took 243.6 days on average for the stock forecasts to be realized with a an average price target met ratio 50.92

Which analyst has the current highest performing score on LUMO (Lumos Pharma) with a proven track record?

PETER LAWSON

Which analyst has the most public recommendations on LUMO (Lumos Pharma)?

Peter Lawson works at BARCLAYS and has 6 price targets and 5 ratings on LUMO

Which analyst is the currently most bullish on LUMO (Lumos Pharma)?

Peter Lawson with highest potential upside - $25.66

Which analyst is the currently most reserved on LUMO (Lumos Pharma)?

Michael Ulz with lowest potential downside - -$0.34

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?